COMMUNIQUÉS West-GlobeNewswire

Pennant Announces Fourth Quarter and Full Year 2024 Earnings Release and Call
14/02/2025
EAGLE, Idaho, Feb. 14, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]
Codexis Announces New Employment Inducement Grants
14/02/2025
REDWOOD CITY, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of [...]
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025
14/02/2025
Received overwhelming shareholder support in favour of take-private transaction with Aditxt Advanced key pipeline programs, engaged regulatory authorities on ATI-1801 and preparing ATI-1701 for an Investigational New [...]
Natural Alternatives International, Inc. Announces 2025 Q2 and YTD Results
14/02/2025
CARLSBAD, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today [...]
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
14/02/2025
TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported [...]
GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders
14/02/2025
In conjunction with (i) the royalty financing deal with HealthCare Royalty (HCRx) announced on January 30, 2025, and (ii) the final terms of the dual proposal to the 2025 OCEANEs holders announced on February 10, 2025, [...]
GENFIT annonce la modification des termes définitifs de la double proposition aux porteurs d’OCEANEs 2025
14/02/2025
Pour faire suite (i) à son annonce du 30 janvier 2025 sur l’accord de financement non dilutif de partage de redevances ( royalty financing ) avec HealthCare Royalty (HCRx) et (ii) à son annonce des termes définitifs de [...]
Dyne Therapeutics Announces Upcoming Presentations at the 2025 MDA Clinical & Scientific Conference
14/02/2025
- Data from DELIVER and ACHIEVE Clinicals Trial to be Presented - - Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on the Use of Splicing Correction as a Prognostic Biomarker of Functional [...]
NurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation
14/02/2025
TORONTO and HAIFA, Israel, Feb. 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (“ NurExone ” or the “ Company ”) is excited to announce that it will be presenting at the [...]
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14/02/2025
SAN FRANCISCO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein [...]
Fate Therapeutics to Present at Upcoming Investor Conferences
14/02/2025
SAN DIEGO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]
Entero Therapeutics Appoints Richard Paolone as CEO
14/02/2025
BOCA RATON, Fla., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (Nasdaq: ENTO) (“Entero” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non- [...]
MEDIA ADVISORY - Patients who have been extra-billed for surgeries in private for-profit clinics demand accountability in the Ontario election: Press conferences in towns across Ontario
14/02/2025
TORONTO, OTTAWA, LONDON and WINDSOR, Ontario, Feb. 14, 2025 (GLOBE NEWSWIRE) -- The Ontario Health Coalition is holding press conferences with patients who have been charged for cataract surgeries or manipulated into [...]
New AI-Powered Startup Merges Technology and Holistic Wellness to Deliver Personalized Health Solutions
14/02/2025
New York, NY, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Samantha Williams , a professional runway and print magazine model for brands like Chi, today announced the launch of the waitlist for YOU Wellness, a new wellness [...]
Turmeric Hack: The 15-Second Morning Ritual Transforming Weight Loss, Backed by Doctor Julian Ross
14/02/2025
LAKELAND, Fla., Feb. 14, 2025 (GLOBE NEWSWIRE) -- A new, turmeric hack is rapidly reshaping the weight-loss conversation, offering a potential breakthrough for those who’ve tried (and failed) with traditional approaches [...]
PetVivo Reports Fiscal Q3 2025 Results
14/02/2025
MINNEAPOLIS, MN, US, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company delivering innovative therapeutics and medical devices for equines and companion [...]
Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational Efficiency
14/02/2025
WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech company, shares a summary of the Company’s 2024 [...]
Zus Health Celebrates Unprecedented Growth, Announcing New Clients and AI-Powered Innovations
14/02/2025
BOSTON, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Zus Health is proud to announce a transformative milestone in its journey to reshape care delivery through data interoperability and actionable insights. Over the past year, Zus [...]
Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation’s Health and Prosperity
14/02/2025
WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech company, today issued a statement from its Founder [...]

Pages